Cancyte
Cancyte is a company dedicated to developing modern molecular and genomic-based diagnostic tests for detecting and treating various types of cancer and infectious diseases. With access to senior scientists, pathologists, and oncologists worldwide, Cancyte aims to provide affordable, quality molecular diagnostics through world-class NABL-ILAC accredited laboratories. The company's mission is to translate basic research into clinical applications, offering reliable diagnostics and continuing research to improve patient care.
Industries
Services
Molecular pathogen testing (PCR)
Laboratory PCR testing for infectious pathogens including HIV, Chikungunya, Malaria, HBV, HCV, Dengue and H1N1.
Viral load testing
Quantitative nucleic acid testing services for monitoring viral load (examples provided for HIV, HBV, HCV).
Serology and rapid tests
Immunoassays and rapid tests including ELISA and point-of-care rapid tests for HIV, HBV, HCV and Dengue (NS1, IgM, IgG).
HLA typing and donor typing
Molecular HLA typing services for donor registries and transplant support; historical throughput reported for large donor cohorts.
Newborn screening services
Screening tests intended for newborns to detect congenital or early-life conditions.
Cancer marker testing
Laboratory testing for cancer biomarkers to support clinical evaluation.
Molecular pathogen testing (PCR)
Laboratory PCR testing for infectious pathogens including HIV, Chikungunya, Malaria, HBV, HCV, Dengue and H1N1.
Viral load testing
Quantitative nucleic acid testing services for monitoring viral load (examples provided for HIV, HBV, HCV).
Serology and rapid tests
Immunoassays and rapid tests including ELISA and point-of-care rapid tests for HIV, HBV, HCV and Dengue (NS1, IgM, IgG).
HLA typing and donor typing
Molecular HLA typing services for donor registries and transplant support; historical throughput reported for large donor cohorts.
Newborn screening services
Screening tests intended for newborns to detect congenital or early-life conditions.
Cancer marker testing
Laboratory testing for cancer biomarkers to support clinical evaluation.
Expertise Areas
- Molecular diagnostics
- Infectious disease diagnostics
- Oncology/genomic biomarker testing
- HLA typing and transplant diagnostics
Key Technologies
- Polymerase chain reaction (PCR)
- Quantitative viral load assays (qPCR/NAAT)
- ELISA and serology assays
- Rapid diagnostic tests (point-of-care serology/antigen)